Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award
Professor at Hunan University of Chinese Medicine , China.
Professor Shuanglin Qin π¨βπ¬, born on October 1, 1989 π, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine π«. With a Ph.D. in Chemical Biology π, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds ππΏ. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award π . Prof. Qin also serves as an editorial member for prestigious journals π and actively contributes to advancing chemical biology and precision medicine π¬β¨.
PROFILEΒ
π Summary of Suitability:
Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine πΏ. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications ππ. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.
π Education & π§ͺ ExperienceΒ
π Education:
-
π 2016β2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University
-
π 2013β2016: Masterβs, School of Pharmacy, Jiangxi Science & Technology Normal University
-
π 2009β2013: Bachelorβs, School of Pharmacy, Hunan University of Chinese Medicine
π§ͺ Experience:
-
π§βπ« 2024β2025: Professor, Hunan University of Chinese Medicine
-
π§βπ« 2019β2024: Associate Professor, Hubei University of Science and Technology
Professional Development ππ
Professor Shuanglin Qin is committed to continual professional advancement π. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China πΌπ¬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research ππ. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination π. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally ππ§ .
Research Focus ππ€
Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery π§ͺπ§¬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine πΏπ. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors π―. His efforts are directed toward developing precision medications with high efficacy and minimal side effects π§ βοΈ. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation ππ±. His lab continues to pave the way in translational cancer research and drug development π.
Awards and Honors πποΈ
-
π₯ Winner, Hunan Science Fund for Distinguished Young Scholars
-
π Winner, ChuTian Scholars Program, Hubei Province
-
π Principal Investigator, National Natural Science Foundation of China projects
-
π§ͺ Recipient, China Postdoctoral Science Foundation funding
-
π Recognized in Youth Talent Programs by Hubei Health Commission & Education Department
-
π Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining
-
π Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology
Publications & Citations π
-
π “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” β Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | π 2025 | π Cited by: 1
-
𧬠“PROTACs coupled with oligonucleotides to tackle the undruggable” β Guangshuai Zhang et al., Journal not specified, 2025 | π 2025 | π Cited by: 0
-
πΏ “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” β Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | π 2024 | π Cited by: 2
-
π¬ “PROTAC technology: From drug development to probe technology for target deconvolution” β Si Yan et al., Journal not specified, 2025 | π 2025 | π Cited by: 19
π Conclusion:
Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.